129 related articles for article (PubMed ID: 28957778)
1. Diagnosing ADHD during active substance use: Feasible or flawed?
van Emmerik-van Oortmerssen K; Vedel E; Kramer FJ; Koeter MW; Schoevers RA; van den Brink W
Drug Alcohol Depend; 2017 Nov; 180():371-375. PubMed ID: 28957778
[TBL] [Abstract][Full Text] [Related]
2. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.
van Emmerik-van Oortmerssen K; van de Glind G; Koeter MW; Allsop S; Auriacombe M; Barta C; Bu ET; Burren Y; Carpentier PJ; Carruthers S; Casas M; Demetrovics Z; Dom G; Faraone SV; Fatseas M; Franck J; Johnson B; Kapitány-Fövény M; Kaye S; Konstenius M; Levin FR; Moggi F; Møller M; Ramos-Quiroga JA; Schillinger A; Skutle A; Verspreet S; ; van den Brink W; Schoevers RA
Addiction; 2014 Feb; 109(2):262-72. PubMed ID: 24118292
[TBL] [Abstract][Full Text] [Related]
4. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria.
van de Glind G; Konstenius M; Koeter MWJ; van Emmerik-van Oortmerssen K; Carpentier PJ; Kaye S; Degenhardt L; Skutle A; Franck J; Bu ET; Moggi F; Dom G; Verspreet S; Demetrovics Z; Kapitány-Fövény M; Fatséas M; Auriacombe M; Schillinger A; Møller M; Johnson B; Faraone SV; Ramos-Quiroga JA; Casas M; Allsop S; Carruthers S; Schoevers RA; Wallhed S; Barta C; Alleman P; ; Levin FR; van den Brink W
Drug Alcohol Depend; 2014 Jan; 134():158-166. PubMed ID: 24156882
[TBL] [Abstract][Full Text] [Related]
5. Criteria and Concurrent Validity of Adult ADHD Section of the Psychiatry Research Interview for Substance and Mental Disorders.
Ramos-Quiroga JA; Díaz-Digon L; Comín M; Bosch R; Palomar G; Chalita JP; Roncero C; Nogueira M; Torrens M; Casas M
J Atten Disord; 2015 Dec; 19(12):999-1006. PubMed ID: 22915013
[TBL] [Abstract][Full Text] [Related]
6. Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers.
Kaye S; Ramos-Quiroga JA; van de Glind G; Levin FR; Faraone SV; Allsop S; Degenhardt L; Moggi F; Barta C; Konstenius M; Franck J; Skutle A; Bu ET; Koeter MWJ; Demetrovics Z; Kapitány-Fövény M; Schoevers RA; van Emmerik-van Oortmerssen K; Carpentier PJ; Dom G; Verspreet S; Crunelle CL; Young JT; Carruthers S; Cassar J; Fatséas M; Auriacombe M; Johnson B; Dunn M; Slobodin O; van den Brink W
J Atten Disord; 2019 Oct; 23(12):1438-1453. PubMed ID: 26922805
[No Abstract] [Full Text] [Related]
7. Prevalence and correlates of ADHD in individuals with substance use disorder in Nigeria.
Umar MU; Salihu AS; Owolabi SD
Atten Defic Hyperact Disord; 2017 Sep; 9(3):189-198. PubMed ID: 28097536
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates.
Rösler M; Retz W; Retz-Junginger P; Hengesch G; Schneider M; Supprian T; Schwitzgebel P; Pinhard K; Dovi-Akue N; Wender P; Thome J
Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):365-71. PubMed ID: 15538605
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
[TBL] [Abstract][Full Text] [Related]
10. The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities.
Van de Glind G; Brynte C; Skutle A; Kaye S; Konstenius M; Levin F; Mathys F; Demetrovics Z; Moggi F; Ramos-Quiroga JA; Schellekens A; Crunelle C; Dom G; van den Brink W; Franck J
Eur Addict Res; 2020; 26(4-5):173-178. PubMed ID: 32599579
[TBL] [Abstract][Full Text] [Related]
11. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders.
Levin FR
J Clin Psychiatry; 2007; 68 Suppl 11():9-14. PubMed ID: 18307376
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity.
Wilens TE; Kwon A; Tanguay S; Chase R; Moore H; Faraone SV; Biederman J
Am J Addict; 2005; 14(4):319-27. PubMed ID: 16188712
[TBL] [Abstract][Full Text] [Related]
13. The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population.
van de Glind G; Van Emmerik-van Oortmerssen K; Carpentier PJ; Levin FR; Koeter MW; Barta C; Kaye S; Skutle A; Franck J; Konstenius M; Bu ET; Moggi F; Dom G; Demetrovics Z; Fatséas M; Schillinger A; Kapitány-Fövény M; Verspreet S; Seitz A; Johnson B; Faraone SV; Ramos-Quiroga JA; Allsop S; Carruthers S; Schoevers RA; ; van den Brink W
Int J Methods Psychiatr Res; 2013 Sep; 22(3):232-44. PubMed ID: 24022983
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing ADHD in adults with substance use disorder: DSM-IV criteria and differential diagnosis.
Levin FR; Upadhyaya HP
J Clin Psychiatry; 2007 Jul; 68(7):e18. PubMed ID: 17685729
[TBL] [Abstract][Full Text] [Related]
15. Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition.
Martinez-Raga J; Szerman N; Knecht C; de Alvaro R
Int J Adolesc Med Health; 2013; 25(3):231-43. PubMed ID: 23846135
[TBL] [Abstract][Full Text] [Related]
16. Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms.
Kaye S; Gilsenan J; Young JT; Carruthers S; Allsop S; Degenhardt L; van de Glind G; van den Brink W
Drug Alcohol Depend; 2014 Nov; 144():70-7. PubMed ID: 25193717
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.
Fatseas M; Debrabant R; Auriacombe M
Curr Opin Psychiatry; 2012 May; 25(3):219-25. PubMed ID: 22449768
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity of Adult ADHD and Its Subtypes With Substance Use Disorder in a Large Population-Based Epidemiological Study.
Capusan AJ; Bendtsen P; Marteinsdottir I; Larsson H
J Atten Disord; 2019 Oct; 23(12):1416-1426. PubMed ID: 26838558
[No Abstract] [Full Text] [Related]
19. Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility.
Adler LA; Guida F; Irons S; Rotrosen J; O'Donnell K
Postgrad Med; 2009 Sep; 121(5):7-10. PubMed ID: 19820269
[TBL] [Abstract][Full Text] [Related]
20. The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.
Brynte C; Aeschlimann M; Barta C; Begeman AHA; Bäcker A; Crunelle CL; Daigre C; De Fuentes-Merillas L; Demetrovics Z; Dom G; López LG; Icick R; Johnson B; Joostens P; Kapitány-Fövény M; Karsinti E; Kiefer F; Konstenius M; Levin FR; Luderer M; Markus W; Matthys F; Moggi F; Palma-Alvarez RF; Paraskevopoulou M; Ramos-Quiroga JA; Schellekens A; Soravia LM; Therribout N; Thomas A; van de Glind G; van Kernebeek MW; Vollstädt-Klein S; Vorspan F; van den Brink W; Franck J
BMC Psychiatry; 2022 Sep; 22(1):625. PubMed ID: 36151539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
